New hope for advanced liver cancer: experimental combo targets tumors directly
NCT ID NCT07282509
First seen Jan 05, 2026 · Last updated May 26, 2026 · Updated 22 times
Summary
This study tests a new treatment for people with advanced liver cancer that has not improved after initial therapy. The treatment delivers a chemotherapy drug directly into the liver's blood supply, combined with other medications given through the body. The goal is to see if this approach is safe and can shrink tumors or slow the disease. About 116 adults aged 18 to 75 with a specific type of liver cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.